Summary
Johnson & Johnson (JNJ) has filed a Form 8-K on April 15, 2025, reporting key financial updates and shareholder returns. The company announced its first-quarter 2025 sales and earnings results, details of which are available in an accompanying press release. This provides investors with crucial performance metrics for the period ending March 30, 2025, enabling an assessment of the company's operational strength and market position. Furthermore, JNJ's Board of Directors has approved a 4.8% increase in its quarterly dividend, raising it from $1.24 to $1.30 per share. This marks the 63rd consecutive year of dividend increases, underscoring the company's commitment to returning capital to shareholders and its financial stability. The annualized dividend now stands at $5.20 per share, reflecting sustained dividend growth.
Key Highlights
- 1JNJ announced its first-quarter 2025 sales and earnings results.
- 2The company reported results for the quarter ended March 30, 2025.
- 3The quarterly dividend has been increased by 4.8%, from $1.24 to $1.30 per share.
- 4This marks the 63rd consecutive year of dividend increases for Johnson & Johnson.
- 5The new annualized dividend rate is $5.20 per share.
- 6The next quarterly dividend is scheduled to be paid on June 10, 2025.